Which of the following is a long acting β2 selective agonist ?
First, the core concept here is beta-2 adrenergic agonists. These are drugs that stimulate beta-2 receptors, leading to bronchodilation. They're used in asthma and COPD. Long-acting means they have a duration of 12 hours or more.
Common beta-2 agonists include albuterol (short-acting), salmeterol (long-acting), and formoterol (which is also long-acting but sometimes considered ultra-short? Wait, formoterol is actually a long-acting, but some sources say it's ultra-short. Hmm. Maybe I should check that. Wait, no, formoterol is a long-acting beta-2 agonist (LABA) with a duration of 12 hours. So the main ones are salmeterol, formoterol, and maybe others like indacaterol, which is even longer.
Now, the question is asking for a long-acting beta-2 selective agonist. So the options would likely include these. The correct answer would be one of them. Let's assume the options are typical ones like albuterol (short), salmeterol (long), formoterol (long), and maybe a non-selective one like epinephrine.
Wait, the user's question has options A to D, but they're not filled. The correct answer is given as, say, option C. But since the options aren't listed, I need to infer based on common choices. Let's say the options are: A. Albuterol, B. Salmeterol, C. Formoterol, D. Epinephrine. Then the correct answer would be B or C.
Wait, but the user's correct answer is not specified here. Oh, the user provided the correct answer as "C. Formoterol" or similar. But since the actual options aren't given, I need to proceed with the general knowledge.
In the explanation, I need to explain that long-acting beta-2 agonists include salmeterol and formoterol. They work by relaxing bronchial smooth muscle, used in COPD and asthma. The wrong options would be short-acting like albuterol, or non-selective like epinephrine.
So the core concept is beta-2 agonists, their duration, and selectivity. The correct answer is a LABA. The incorrect options would be non-selective or short-acting. The clinical pearl is to remember the LABAs for long-term management.
Putting it all together, the explanation should cover these points, making sure to differentiate between short and long-acting, and selective vs. non-selective agonists. Also, mention the duration and mechanism of action.
**Core Concept**
Long-acting β2-selective agonists (LABAs) are used in asthma and COPD to provide sustained bronchodilation by stimulating β2-adrenergic receptors in bronchial smooth muscle. These agents have a duration of action ≥12 hours, unlike short-acting β2 agonists (SABAs).
**Why the Correct Answer is Right**
**Formoterol** (if it were the correct answer